中信证券研报表示，展望2026年，宏观金融条件稳定指向银行经营环境稳定，预计银行息差见底，实体 部门风险缓释中，收入与盈利同步修复。行业投资价值来源于，银行系统性风险再评估带来的净资产重 估，以及稳定回报特征驱动资金流入板块、带来核心权益资产价值重估。2026年，预计银行板块将继续 演绎估值提升方向。 ...

Group 1 - The core viewpoint is that the market is expected to experience a震荡向上 (upward fluctuation) trend at the beginning of the year, driven by factors such as improved investor sentiment and liquidity conditions [2][3][4] - The anticipated market performance in 2025 is positioned as the third-best in the last decade and sixth-best in the last twenty years, indicating a significant structural bull market [2] - The balance between external and internal demand is highlighted as a key factor for 2026, with expectations of policies aimed at boosting domestic demand [2][3] Group 2 - The spring market is expected to continue its upward trend, supported by improved PMI data, abundant micro liquidity, and positive policy signals [4][6] - The market is likely to see a "开门红" (opening red) at the start of the year, with a strong performance from sectors such as technology, non-bank financials, and consumer goods [3][7] - The focus on new growth areas such as AI, energy storage, and solid-state batteries is emphasized, with a shift in demand patterns away from traditional sectors [3][10] Group 3 - The investment sentiment is high, with a strong supply of funds and supportive economic data, indicating a favorable environment for the spring market [5][6] - The potential for a "牛市" (bull market) in 2026 is reinforced by multiple positive factors, including macroeconomic policy support and a recovery in corporate earnings [9][12] - Recommendations for sector allocation include emerging growth themes and cyclical opportunities, particularly in AI, robotics, and renewable energy [10][12][13]

Core Insights - The tourism market is expected to see a strong start in 2026, with domestic travel during the New Year holiday projected to increase by approximately 5% in terms of the number of trips and 6% in total spending compared to the 2024 New Year holiday [1] Group 1: Market Performance - Domestic tourism performance aligns with expectations, while inbound and outbound travel numbers have exceeded forecasts [1] - Duty-free sales have shown significant growth, with offshore duty-free sales increasing by about 50% compared to the 2024 New Year holiday [1] - Hotel occupancy rates have improved, although prices still show a gap compared to 2024 [1] Group 2: Sector Highlights - Scenic spots have generally performed well, with prominent mountainous scenic areas standing out [1] - The upcoming Spring Festival, with a 9-day holiday, is expected to further enhance travel enthusiasm, indicating a positive outlook for the tourism market [1]

Group 1 - The core viewpoint of the articles indicates a positive outlook for the Chinese stock market in 2026, driven by factors such as AI innovation, supportive policies for private enterprises, and improved corporate earnings [1][4][5] - The Shanghai Composite Index achieved an 18.41% increase in 2025, marking its best annual performance since 2020, with the Shenzhen Component Index and ChiNext Index rising by 29.87% and 49.57% respectively [1] - Domestic and foreign institutions are increasingly optimistic about Chinese assets, particularly in the technology sector, which is expected to be a key growth driver in 2026 [2][4][6] Group 2 - Domestic securities firms, such as CITIC Securities, emphasize a shift from valuation-driven gains to performance-driven earnings, suggesting that investors should focus on companies' earnings rather than expecting further valuation increases [2][3] - International investment banks, including UBS and Morgan Stanley, predict a favorable environment for Chinese stocks, citing ongoing support for innovation and the resilience of corporate earnings in a complex trade environment [4][5] - The AI sector is highlighted as a critical area for investment, with expectations for new applications and growth in related industries such as semiconductors and advanced manufacturing [6][7] Group 3 - The overall sentiment among foreign institutions is that structural improvements in the Chinese market will support a broader upward trend, with predictions of significant earnings growth for Chinese companies in 2026 and 2027 [4][5] - The focus on AI and technology is expected to enhance the profitability of the Chinese stock market, with a notable increase in R&D investments driving the digital economy's contribution to GDP [6][7] - Asset allocation strategies suggest an overweight position in Chinese stocks and gold, with a cautious approach to gold due to its current high valuation [7]

公司在全球拥有8个生产基地和2个在建生产基地，销售公司及办公室覆盖7个国家及地区，售后服务网 络覆盖24个国家及地区。 市场地位（按2024年出货量计），在全球消费电池制造商中名列第三，市场份额为11.7%。在全球储能 电池市场名列第二，市场份额为17.2%。 全球消费电池出货量预计2025—2029年复合年增长率达26.2%。全球电动汽车销量预计2025—2029年复 合年增长率达20.1%。全球储能电池年出货量预计2025—2029年复合年增长率达23.1%。 亿纬锂能向港交所主板递交上市申请，中信证券为其独家保荐人。亿纬锂能是全球少数在消费电池、动 力电池及储能电池领域均全球领先，能够服务社会经济全场景应用的锂电池平台企业，产品广泛应用于 智能生活、绿色交通和能源转型。 （文章来源：证券时报网） ...

Core Viewpoint - Zhenqu Technology has submitted its listing application to the Hong Kong Stock Exchange, with CITIC Securities and Guotai Junan as joint sponsors. The company focuses on electric vehicle (EV) control solutions and has developed a layered solution set that includes power modules, motor controllers, and power bricks, allowing customers to choose different levels of system integration [1] Group 1: Company Overview - Zhenqu Technology pioneered the concept of "power brick" and achieved mass production of the main drive power brick in 2021, significantly simplifying the assembly of control systems, enhancing platform reusability, and shortening development cycles [1] - The company has expanded its offerings to low-power controllers and domain controllers in the power domain and chassis domain [1] Group 2: Market Position and Achievements - As of September 30, 2025, the company has secured 50 design wins from 13 OEMs, with solutions applied to 82 vehicle models, 54 of which have entered mass production [1] - According to Frost & Sullivan, the company's rankings in the Chinese market by installation volume are as follows: - Motor controllers ranked 11th in 2024 and 8th in the first nine months of 2025 - Dual motor controllers ranked 3rd in the first nine months of 2025 - Main drive power bricks ranked 1st in 2024 and 2nd in the first nine months of 2025 - Power bricks installed in dual motor controllers ranked 1st in the first nine months of 2025 - Power modules ranked 8th in 2024 and 7th in the first nine months of 2025 [1] Group 3: Business Expansion - The company has leveraged its core technology to expand its business into emerging fields such as electric vertical takeoff and landing vehicles (eVTOL) and embodied intelligence [1]

Group 1 - Company has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the exclusive sponsor [1] - Company is a research-driven biopharmaceutical firm based in China, focusing on significant unmet medical needs in oncology, autoimmune diseases, and metabolic diseases [1] - As of December 24, 2025, the company has established a comprehensive and differentiated product pipeline, including two commercialized products, two core products in clinical stages, one candidate in clinical stage, and three candidates in preclinical stage [1] Group 2 - The commercialized products include BPI-D0316, a third-generation EGFR tyrosine kinase inhibitor for EGFR mutation-positive non-small cell lung cancer (NSCLC), which has been approved and included in the National Medical Insurance Drug List in China [1] - Another commercialized product, D-1553, is a KRAS G12C inhibitor, the first self-developed product in this target area to enter clinical stages in China, also approved and included in the National Medical Insurance Drug List [1] - The company has signed an agreement with Zhengda Tianqing to grant exclusive rights for the development, registration, production, and commercialization of D-1553 in mainland China [1] Group 3 - The core clinical-stage product D-2570 is undergoing a registrational Phase III clinical trial for plaque psoriasis and ulcerative colitis (UC), with plans to initiate additional trials for psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), and vitiligo [2] - Tairisig is an oral selective estrogen receptor degrader (SERD) currently in a registrational Phase III clinical trial for ER+/HER2- breast cancer [2] - The global and Chinese markets for oncology drugs, targeted oncology drugs, psoriasis drugs, UC drugs, and SERD drugs show significant growth potential, with the Chinese targeted oncology drug market expected to reach $61.6 billion by 2035 [2]

Group 1 - The core viewpoint is that 2026 will be a crucial year for China's economic work, marking the beginning of the "15th Five-Year Plan" and the transition to a period of solid foundation and comprehensive efforts [1] - Analysts from ten major securities firms provide insights on market trends, industry allocations, and major investment opportunities for 2026, aiming to clarify the investment landscape for investors [1] Group 2 - CITIC Securities predicts that A-share company profit growth will show a trend of low growth initially followed by a recovery [2] - The market is expected to be influenced by the US-China trade agreement and the US midterm elections, with three phases of market performance anticipated [4] - Key investment themes include global pricing power in manufacturing, the expansion of Chinese companies overseas, the continuation of the tech trend with AI, and the potential recovery of domestic demand [4] Group 3 - CICC highlights that the restructuring of international order and China's industrial innovation will support A-share performance, with a market trend of initial growth followed by stabilization [5] - Analysts suggest focusing on growth sectors such as AI applications, industries benefiting from external demand, and cyclical sectors nearing recovery [7] Group 4 - GF Securities indicates that the A-share market is likely to maintain a "slow bull" pattern, with corporate profit structures undergoing significant changes [8][10] - The expected nominal GDP growth for China in 2026 is projected to reach 6.45%, significantly higher than in 2025, supporting the overall improvement in corporate profits [21] Group 5 - Analysts from various firms suggest that the market will shift from valuation-driven to profit-driven dynamics, with traditional and emerging industries contributing to profit recovery [15][17] - The focus on new production capabilities and the impact of policies like "anti-involution" are expected to improve competition in traditional industries and boost domestic demand [17] Group 6 - Analysts predict that more industries will enter a profit recovery phase in 2026, with nominal economic recovery and price increases being the most evident trends [18][20] - UBS forecasts that A-share company profit growth could rise to 8% due to improved nominal GDP growth and the narrowing of PPI declines [32] Group 7 - Analysts recommend focusing on four main investment themes: technological self-reliance, consumer sector recovery, "anti-involution" related sectors, and the global competitiveness of Chinese companies [34] - The market is expected to maintain a balanced style between growth and value, with cyclical sectors likely to outperform defensive sectors as the economy recovers [34]

Core Viewpoint - The analysis highlights the expected trends and investment opportunities in the A-share market for 2026, emphasizing a shift towards profitability-driven growth amid a recovering economy and evolving global dynamics [1][28]. Group 1: Economic Outlook - 2026 marks the beginning of the "15th Five-Year Plan," focusing on solidifying foundations and comprehensive efforts for economic modernization [1][28]. - The A-share market is anticipated to experience a recovery in corporate profitability, with a projected increase in earnings growth to 8% driven by improved nominal GDP growth and narrowing PPI declines [53][52]. Group 2: Market Phases - The market is expected to be segmented into three phases influenced by U.S.-China trade agreements and U.S. midterm elections, with a potential for sustained growth in a stable external environment [3][30]. - Analysts predict a "slow bull" market pattern, with corporate profitability stabilizing and the return of investment interest from insurance and high-net-worth individuals [7][34]. Group 3: Investment Themes - Key investment themes include: - The manufacturing sector's pursuit of global pricing power, particularly in non-ferrous metals, chemicals, and new energy [3][30]. - The globalization of Chinese enterprises, opening up new market opportunities in machinery, innovative pharmaceuticals, and military industries [3][30]. - Continued growth in the AI sector, with a focus on semiconductors, computing power, and AI applications [3][30]. - Recovery opportunities in domestic demand, particularly in sectors with potential for valuation elasticity [3][30]. Group 4: Sector Focus - Analysts suggest focusing on sectors with clear growth trends, such as AI, where capital expenditure is expected to expand, and cyclical industries like chemicals and renewable energy that may benefit from policy support [5][38]. - The technology sector is projected to maintain high profit growth, although the valuation gap with traditional sectors may pose challenges [40][42]. Group 5: Policy and Market Dynamics - The market is expected to transition from valuation-driven to profitability-driven dynamics, supported by fiscal policies aimed at boosting domestic demand and improving competition in traditional industries [38][40]. - Analysts emphasize the importance of capital market reforms to enhance flexibility and attract long-term investments, particularly in emerging industries [45][48].

Core Viewpoint - The article discusses the outlook for the A-share market in 2026, emphasizing the importance of economic work and investment strategies as China enters a critical period of its "14th Five-Year Plan" [1][2]. Group 1: Market Trends and Economic Outlook - A-share company profit growth is expected to show a "low first, high later" trend in 2026, influenced by the US-China trade dynamics and the upcoming US midterm elections [3][5]. - The international order's restructuring and China's industrial innovation are anticipated to support A-share performance, with a market trend of initial growth followed by stabilization [6][8]. - The nominal GDP growth in China is projected to reach 6.45% in 2026, significantly higher than in 2025, indicating a recovery in corporate earnings [21]. Group 2: Investment Opportunities and Sector Focus - Key investment themes include the global pricing power in manufacturing, the expansion of Chinese companies overseas, the continuation of the tech trend with AI, and the potential recovery in domestic demand [5][8][19]. - Analysts suggest focusing on sectors with clear growth trends, such as AI applications, machinery, innovative pharmaceuticals, and energy equipment [5][8][19]. - The A-share market is expected to maintain a "slow bull" pattern, with a focus on industries experiencing supply constraints and clear growth trends, such as AI and energy storage [11][25]. Group 3: Policy and Structural Changes - The article highlights the need for policies that support long-term market stability and the development of new industries, particularly in technology and innovation [6][17][24]. - The "anti-involution" policies are expected to improve competition in traditional industries and stimulate domestic demand, contributing to overall market recovery [15][17]. - The capital market is anticipated to transition from valuation-driven to profit-driven dynamics, with a focus on sectors that can benefit from both traditional and emerging growth drivers [15][19].